Adrian Rawcliffe - Chief Executive Officer, Director at Adaptimmune Therapeutics PLC

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
ADAPY on OTC
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Adrian Rawcliffe since 11 Mar 2025

Holdings reported by Adrian Rawcliffe for Adaptimmune Therapeutics PLC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
American Depositary Shares representing Ordinary Shares 44,327 $25,745 $0.5808 17 Jan 2025 Direct
Option to purchase Ordinary Shares 3,428,832 20 Feb 2025 Direct Ordinary Shares

Transactions reported by Adrian Rawcliffe for Adaptimmune Therapeutics PLC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.